The global hernia repair devices market size is estimated at USD 5.37 billion in 2024, grew to USD 5.64 billion in 2025 and is predicted to hit around USD 8.80 billion by 2034, expanding at a CAGR of 5.07% between 2024 and 2034. The North America hernia repair devices market size accounted for USD 2.74 billion in 2024 and is anticipated to grow at a fastest CAGR of 5.14% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Hernia Repair Devices Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Hernia Repair Devices Market, by Product Type, 2024-2034
8.1.1 Hernia Mesh
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hernia Fixation Devices
8.1.2.1. Market Revenue and Forecast (2021-2034)
9.1. Hernia Repair Devices Market, by Surgery Type, 2024-2034
9.1.1. Inguinal Hernia
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Umbilical Hernia
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Incisional Hernia
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Femoral Hernia
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Others
9.1.5.1. Market Revenue and Forecast (2021-2034)
10.1. Hernia Repair Devices Market, by Procedure Type, 2024-2034
10.1.1. Open Surgery
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Laparoscopic Surgery
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.1.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.2.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.3.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Surgery Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Procedure Type (2021-2034)
12.1. B Braun Melsungen AG
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Cook Medical
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medtronic Plc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. W.L. Gore & Associates
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Ethicon Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. C.R Bard Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Atrium
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. LifeCell Corporation
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Baxter International
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Hernia mesh S.R.L.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client